Lataa...
Effect of P-glycoprotein on flavopiridol sensitivity
Flavopiridol is the first potent inhibitor of cyclin-dependent kinases (CDKs) to enter clinical trials. Little is known about mechanisms of resistance to this agent. In order to determine whether P-glycoprotein (Pgp) might play a role in flavopiridol resistance, we examined flavopiridol sensitivity...
Tallennettuna:
| Päätekijät: | , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Nature Publishing Group
2001
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2363628/ https://ncbi.nlm.nih.gov/pubmed/11355953 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1054/bjoc.2000.1688 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|